Eko Health realized that the one tool that every doctor has on their neck, the stethoscope, has not been updated for 200 years, and designed a way for AI to be incorporated for early detection of heart failure, co-founder and CEO Connor Landgraf says. In this episode of Bloomberg Intelligence’s Vanguards of Health Care podcast, Landgraf talks with BI analyst Matt Henriksson about how the company was founded and how the Sensora Cardiac Disease Detection Platform can provide early identification of heart failure as a first-of-its-kind non-invasive test. By using algorithms and big data to detect small signals from electrocardiograms that are invisible to physicians, the technology can help shift the overarching trend in health care away from being reactive to patients symptoms, when it may be too late for treatment, and toward detecting disease before symptoms arise.

See omnystudio.com/listener for privacy information.